Agilent Technologies, Inc. (NYSE:A) Stock Position Raised by CANADA LIFE ASSURANCE Co

CANADA LIFE ASSURANCE Co grew its position in shares of Agilent Technologies, Inc. (NYSE:A) by 4.8% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 331,599 shares of the medical research company’s stock after buying an additional 15,080 shares during the quarter. CANADA LIFE ASSURANCE Co owned approximately 0.12% of Agilent Technologies worth $44,536,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also recently added to or reduced their stakes in the company. CKW Financial Group raised its stake in shares of Agilent Technologies by 114.9% in the 4th quarter. CKW Financial Group now owns 187 shares of the medical research company’s stock valued at $25,000 after acquiring an additional 100 shares in the last quarter. Global X Japan Co. Ltd. raised its position in shares of Agilent Technologies by 161.1% in the fourth quarter. Global X Japan Co. Ltd. now owns 188 shares of the medical research company’s stock valued at $25,000 after purchasing an additional 116 shares during the period. Redwood Park Advisors LLC acquired a new stake in shares of Agilent Technologies in the fourth quarter worth $27,000. Lee Danner & Bass Inc. bought a new stake in shares of Agilent Technologies during the 4th quarter worth $29,000. Finally, Hanson & Doremus Investment Management grew its stake in Agilent Technologies by 66.5% in the 4th quarter. Hanson & Doremus Investment Management now owns 263 shares of the medical research company’s stock valued at $35,000 after buying an additional 105 shares during the last quarter.

Analysts Set New Price Targets

A number of equities research analysts have issued reports on the stock. Barclays decreased their price target on shares of Agilent Technologies from $138.00 to $115.00 and set an “equal weight” rating for the company in a report on Thursday, April 10th. Robert W. Baird lowered their target price on Agilent Technologies from $161.00 to $159.00 and set an “outperform” rating on the stock in a report on Thursday, February 27th. StockNews.com upgraded Agilent Technologies from a “hold” rating to a “buy” rating in a report on Tuesday, December 24th. Wells Fargo & Company reduced their price objective on Agilent Technologies from $155.00 to $135.00 and set an “overweight” rating for the company in a research report on Thursday. Finally, TD Cowen boosted their target price on shares of Agilent Technologies to $135.00 and gave the stock a “buy” rating in a research report on Thursday, April 10th. Seven research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $144.58.

Agilent Technologies Trading Down 0.3 %

Shares of A stock opened at $102.38 on Friday. The firm has a fifty day moving average of $119.55 and a 200-day moving average of $132.49. The stock has a market cap of $29.19 billion, a price-to-earnings ratio of 23.54, a P/E/G ratio of 2.89 and a beta of 1.19. Agilent Technologies, Inc. has a 52-week low of $96.43 and a 52-week high of $155.35. The company has a debt-to-equity ratio of 0.56, a quick ratio of 1.66 and a current ratio of 2.20.

Agilent Technologies (NYSE:A) last posted its quarterly earnings results on Wednesday, February 26th. The medical research company reported $1.31 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.27 by $0.04. The firm had revenue of $1.68 billion during the quarter, compared to analyst estimates of $1.67 billion. Agilent Technologies had a net margin of 19.27% and a return on equity of 25.56%. On average, equities research analysts forecast that Agilent Technologies, Inc. will post 5.54 earnings per share for the current fiscal year.

Agilent Technologies Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, April 23rd. Stockholders of record on Tuesday, April 1st will be paid a $0.248 dividend. The ex-dividend date is Tuesday, April 1st. This represents a $0.99 annualized dividend and a dividend yield of 0.97%. Agilent Technologies’s dividend payout ratio is presently 22.76%.

Insider Transactions at Agilent Technologies

In other news, Director Daniel K. Podolsky sold 1,819 shares of the business’s stock in a transaction that occurred on Monday, March 31st. The stock was sold at an average price of $116.46, for a total value of $211,840.74. Following the transaction, the director now directly owns 35,737 shares of the company’s stock, valued at $4,161,931.02. The trade was a 4.84 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, VP Rodney Gonsalves sold 1,908 shares of the firm’s stock in a transaction on Monday, March 17th. The shares were sold at an average price of $121.98, for a total value of $232,737.84. Following the sale, the vice president now directly owns 21,786 shares of the company’s stock, valued at $2,657,456.28. This represents a 8.05 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders have sold 5,638 shares of company stock valued at $731,229.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.